IFN-γ suspends the killing license of anti-tumor CTLs

Journal of Clinical Investigation

Volumn 110, Issue 10, 2002, Pages 1407-1409

  Lukacher, Aron E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ANTINEOPLASTIC ACTIVITY; CELL KILLING; CYTOTOXIC T LYMPHOCYTE; CYTOTROPHOBLAST; GENETIC TRANSCRIPTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NATURAL KILLER CELL; NONHUMAN; NOTE; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD94; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; MICE; MODELS, IMMUNOLOGICAL; NEOPLASMS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036856108     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200217209     Document Type: Note

References (21)

1. +T cells. Curr. Opin. Immunol. 13:465-470.
2. Moser, J.M., Byers, A.M., and Lukacher, A.E. 2002. NK cell receptors in antiviral immunity. Curr. Opin. Immunol. 14:509-516.
3. + T cells. Nat. Immunol. 2:430-435.
4. Malmberg, K.-J., et al. 2002. IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J. Clin. Invest. 110:1515-1523. doi:10.1172/JCI200215564.
5. Braud, V.M., et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:795-799.
6. b. J. Exp. Med. 188:1841-1848.
7. + T cell responses. Nat. Immunol. 3:189-195.
8. + T cells. J. Immunol. 169:1444-1452.
9. Miller, J.D., er al. 2002. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells. J. Immunol. 169:693-701.
10. Ugolini, S., and Vivier, E. 2000. Regulation of T cell function by NK cell receptors for classical MHC class I molecules. Curr. Opin. Immunol. 12:295-300.
11. Vetter, C.S., et al. 2000. Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma. J. Invest. Dermatol. 114:941-947.
12. + T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma. Immunol. Lett. 81:125-132.
13. Speiser, D.E., et al. 1999. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med. 190:775-782.
14. Vales-Gomez, M., et al. 1999. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18:4250-4260.
15. Mingari, M.C., Moretta, A., and Moretta, L. 1998. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses. Immunol. Today. 19:153-157.
16. Cohen, G.B., et al. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 10:661-671.
17. Tomasec, P., et al. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science. 287:1031-1033.
18. Diefenbach, A., Jensen, E.R., Jamieson, A.M., and Raulet, D.H. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate turnout immunity. Nature. 413:165-171.
19. Groh, V., et al. 2001. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255-260.
20. Cerboni, C., et al. 2001. Synergistic effect of IFN-γ and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Eur. J. Immunol. 31:2926-2935.
21. Rouas-Freiss, N., Marchal-Bras, G., Menier, C., Dausset, J., and Carosella, E.D. 1997. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA. 94:11520-11525.